A Safety and Pharmacokinetic Study of TAK-228 in Combination With TAK-117 in Adult Participants With Advanced Nonhematologic Malignancies

NCT01899053 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Nonhematologic Malignancies

Interventions

DRUG: TAK-228
DRUG: TAK-117

Sponsor

Millennium Pharmaceuticals, Inc.